IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biodexa Pharmaceuticals PLC

CUSIP: 59564R807 | 7 institutional holders

Quarters

Q2 2025Q1 2025Q4 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2025

Gamma Investing LLC11,940
0.0% of portfolio›$10.3K
SBI Securities Co., Ltd.5,668
0.0% of portfolio›$4.9K
UBS Group AG1,989
0.0% of portfolio›$1.7K
Rhumbline Advisers69
0.0% of portfolio›$59
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Gamma Investing LLC
11,940$10.3K0.0%IndexVery LowFoster City, CA2025-07-14
SBI Securities Co., Ltd.
5,668$4.9K0.0%GrowthLowTokyo, Mexico2025-08-08
UBS Group AG
1,989$1.7K0.0%CoreMediumZurich, Switzerland2025-08-14
Rhumbline Advisers
69$590.0%IndexVery LowBoston, MA2025-08-12
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2025-08-12